IOSP · Innospec Inc. - Financials

Annual line items from SEC XBRL filings, sourced from EDGAR's Company Facts API with fallback to the quarterly Financial Statement Data Sets. See issuer overview for Form 4 activity and 10-K signals.

Price · IOSP

1Y 3Y 5Y Max

Annual Quarterly

Income Statement

Line item	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Revenue	$1.78B	$1.85B	$1.95B	$1.96B	$1.48B	$1.19B
Cost of Revenue	$1.29B	$1.30B	$1.36B	$1.38B	$1.05B	$850.40M
Gross Profit	$492.40M	$542.90M	$591.10M	$586.70M	$434.90M	$342.70M
R&D	$51.00M	$47.80M	$41.70M	$38.70M	$37.40M	$30.90M
SG&A	$285.10M	$314.00M	$387.80M	$360.70M	$267.20M	$237.00M
Total Operating Expenses	$362.90M	$365.00M	$429.50M	$399.40M	$302.80M	$309.00M
D&A	$43.60M	$43.50M	$39.30M	$40.10M	$42.70M	$46.00M
Operating Income	$129.50M	$177.90M	$161.60M	$187.30M	$132.10M	$33.70M
Interest Expense	$0	$0	$0	$0	$0	$800.0K
Income Tax	$21.50M	$5.60M	$35.30M	$51.60M	$41.30M	$11.00M
Net Income	$116.60M	$35.60M	$139.10M	$133.00M	$93.10M	$28.70M
EPS - Basic	$4.69	$1.43	$5.60	$5.37	$3.78	$1.17
EPS - Diluted	$4.67	$1.42	$5.56	$5.32	$3.75	$1.16

Balance Sheet

Line item	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Cash & Equivalents	$292.50M	$289.20M	$203.70M	$147.10M	$141.80M	$105.30M
Accounts Receivable	$342.30M	$341.70M	$359.80M	$334.60M	$284.50M	$221.40M
Inventory	$329.30M	$301.00M	$300.10M	$373.10M	$277.60M	$220.00M
Accounts Payable	$174.70M	$163.80M	$163.60M	$165.30M	$148.70M	$98.70M
Current Assets	$1.00B	$956.60M	$885.70M	$872.60M	$728.10M	$566.20M
Total Assets	$1.83B	$1.73B	$1.71B	$1.60B	$1.57B	$1.40B
Current Liabilities	$360.10M	$371.40M	$371.50M	$405.80M	$336.60M	$252.40M
Long-term Debt	-	-	-	-	-	$0
Total Liabilities	$499.50M	$518.60M	$557.80M	$563.30M	-	-
Stockholders' Equity	$1.33B	$1.21B	$1.15B	$1.04B	$1.03B	$944.40M
Retained Earnings	$1.10B	$1.02B	$1.03B	$924.20M	$822.90M	$758.60M

Cash Flow

Line item	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Operating Cash Flow	$138.30M	$184.50M	$207.30M	$81.70M	$93.20M	$145.90M
Investing Cash Flow	($75.10M)	($62.00M)	($111.80M)	($42.10M)	($36.20M)	($29.70M)
Financing Cash Flow	($63.90M)	($35.30M)	($39.00M)	($33.70M)	($20.00M)	($86.80M)
CapEx	-	-	-	-	-	-
Free Cash Flow	-	-	-	-	-	-

Ratios

Metric	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Profitability
Gross margin	27.7%	29.4%	30.3%	29.9%	29.3%	28.7%
Operating margin	7.3%	9.6%	8.3%	9.5%	8.9%	2.8%
EBITDA margin	9.7%	12.0%	10.3%	11.6%	11.8%	6.7%
Net margin	6.6%	1.9%	7.1%	6.8%	6.3%	2.4%
Free cash flow margin	-	-	-	-	-	-
FCF / Net income	-	-	-	-	-	-
R&D / Revenue	2.9%	2.6%	2.1%	2.0%	2.5%	2.6%
SG&A / Revenue	16.0%	17.0%	19.9%	18.4%	18.0%	19.9%
Effective tax rate	15.6%	13.6%	20.2%	28.0%	30.7%	27.7%
Return on assets	6.4%	2.1%	8.1%	8.3%	5.9%	2.1%
Return on equity	8.8%	2.9%	12.1%	12.8%	9.0%	3.0%
Return on invested capital	-	-	-	-	-	2.6%
Liquidity
Current ratio	2.79	2.58	2.38	2.15	2.16	2.24
Quick ratio	1.88	1.77	1.58	1.23	1.34	1.37
Cash ratio	0.81	0.78	0.55	0.36	0.42	0.42
Leverage
Debt / Equity	-	-	-	-	-	0.00
Debt / Assets	-	-	-	-	-	0.00
Debt / EBITDA	-	-	-	-	-	0.00
Interest coverage	-	-	-	-	-	42.1x
Equity multiplier	1.38	1.43	1.49	1.54	1.52	1.48
Liabilities / Assets	0.27	0.30	0.33	0.35	-	-
Efficiency
Asset turnover	0.97	1.06	1.14	1.22	0.94	0.85
Inventory turnover	3.90	4.33	4.52	3.69	3.78	3.87
Days sales outstanding	70d	68d	67d	62d	70d	68d
Days inventory outstanding	93d	84d	81d	99d	97d	94d
Days payable outstanding	50d	46d	44d	44d	52d	42d
Cash conversion cycle	114d	106d	104d	117d	115d	120d
Valuation
P / E	16.4x	77.5x	22.2x	19.3x	24.1x	78.2x
P / B	1.4x	2.3x	2.7x	2.5x	2.2x	2.4x
P / S	1.1x	1.5x	1.6x	1.3x	1.5x	1.9x
EV / EBITDA	9.4x	11.2x	14.3x	10.7x	12.0x	26.9x
Growth
Revenue growth (YoY)	-3.7%	-5.3%	-0.8%	32.4%	24.3%	-21.2%
Revenue CAGR (3y)	-3.3%	7.6%	17.8%	9.1%	18.9%	-3.0%
Revenue CAGR (5y)	8.3%	4.0%	17.1%	8.5%	10.9%	3.3%
Gross profit growth (YoY)	-9.3%	-8.2%	0.7%	34.9%	26.9%	-26.5%
Operating income growth (YoY)	-27.2%	10.1%	-13.7%	41.8%	292.0%	-77.5%
Net income growth (YoY)	227.5%	-74.4%	4.6%	42.9%	224.4%	-74.4%
EPS growth (YoY)	228.9%	-74.5%	4.5%	41.9%	223.3%	-74.4%
EPS CAGR (3y)	-4.3%	-27.7%	68.6%	5.4%	2.8%	-22.8%
EPS CAGR (5y)	32.1%	-20.7%	10.0%	16.1%	2.4%	-24.9%
FCF growth (YoY)	-	-	-	-	-	-
FCF CAGR (5y)	-	-	-	-	-	-
Book value growth (YoY)	9.5%	5.6%	10.5%	0.5%	9.3%	2.8%

Sales by segment

From XBRL dimensional facts in the 10-K period ending 2025-12-31.

Business segments

$1.31B total

Fuel Specialties$509.40M · 38.8%

Performance Chemicals$409.20M · 31.1%

Oilfield Services$395.10M · 30.1%

Geographic

$2.12B total

US$951.70M · 44.8%

GB$793.20M · 37.3%

Rest Of World$379.00M · 17.8%

Stability scores

Altman Z′

FY 2025 · bankruptcy risk

3.06

Safe

Private-firm variant - uses book equity instead of market cap. > 2.90 safe · 1.23-2.90 grey · < 1.23 distress.

Piotroski F-score

FY 2025 · 9-point quality

6/9

Neutral

✓Net income positive
✓Operating cash flow positive
✓ROA improved YoY
✓Cash flow > net income
-Long-term debt decreased
✓Current ratio improved
✓No share dilution
✗Gross margin improved
✗Asset turnover improved

Peer comparison

Same SIC group: Chemicals & Allied Products

Company	Revenue (last FY)	Net margin	ROE
FMC	$3.47B	-64.6%	-108.1%
CC	$5.81B	-6.6%	-154.4%
OLN	$6.78B	-1.5%	-5.5%
NGVT	$1.17B	-14.3%	-562.6%
HUN	$6.04B	-3.1%	-6.9%

Comparing INNOSPEC INC. against the 5 most active filers in the same SIC group.

Dividends

$1.79/share trailing 12 months · +9.8% YoY

Ex-date	Per share
May 19, 2026	$0.9200
Nov 18, 2025	$0.8700
May 20, 2025	$0.8400
Nov 18, 2024	$0.7900
May 17, 2024	$0.7600
Nov 17, 2023	$0.7200
May 19, 2023	$0.6900
Nov 18, 2022	$0.6500
May 16, 2022	$0.6300
Nov 15, 2021	$0.5900
May 14, 2021	$0.5700
Nov 16, 2020	$0.5200
May 15, 2020	$0.5200
Nov 18, 2019	$0.5200
May 20, 2019	$0.5000
Nov 16, 2018	$0.4500
May 18, 2018	$0.4400
Nov 15, 2017	$0.3900
May 18, 2017	$0.3800
Nov 10, 2016	$0.3400
May 12, 2016	$0.3300
Nov 12, 2015	$0.3100
May 14, 2015	$0.3000
Nov 13, 2014	$0.2800